At the Cancer Institute of Prisma Health, our core philosophy is anchored in providing the most effective, most targeted cancer care available in the world. We are dedicated to enhancing the quality of life for those with cancer in our community and beyond through clinical excellence and research. We understand that cancer care is about comfort, compassion and enhanced access to care, so we focus on treating the whole person, not just the disease. This means patients do not have to leave the Upstate to receive high-quality cancer care. In fact, many people travel to Prisma Health Cancer Institute from outside our state to receive care.
Subscribe to our eNewsletter for news and updates from the Cancer Institute.
With a focus on translating research to personalized cancer treatment, Prisma Health’s Institute for Translational Oncology Research (ITOR) provides some of the most advanced cancer treatments available anywhere in the world.
Our Multidisciplinary Center (MDC) brings together a number of specialists and care providers in one place, allowing a patient to accomplish in one morning visit what previously may have taken several trips over a few weeks.
Prisma Health’s Center for Integrative Oncology and Survivorship (CIOS) is a patient-centered program that integrates evidenced-based complementary therapies with traditional cancer care to treat the “whole patient,” encompassing mind, body and spirit.
The National Cancer Institute proclaimed Prisma Health Cancer Institute among the nation’s best in research with a recent award of $6.7 million to conduct clinical trials and research studies aimed at improving patient outcomes and reducing health disparities. Prisma Health is the only community-based site in S.C. to receive the award. Clinical trials focus on improving cancer prevention, cancer control, screening for early cancers and post-treatment surveillance, while cancer care delivery research focuses on quality of life and understanding the diverse and multi-level factors that affect access to and quality of care.
1000th BMT PatientPrisma Health’s Cancer Institute marked its 1000th stem cell transplant in October, a major milestone of providing 25 years of innovative transplant therapies in the Upstate. Learn more here.
If you or someone you know has been diagnosed with cancer, you know how overwhelming it can feel. The more information you have, the better prepared you’ll be to talk with your physician and help make decisions. Watch this video for a simple explanation of the basics of cancer and common treatment options.
Prisma Health’s Cancer Institute has been awarded $6.7 million to conduct clinical trials and research studies aimed at improving patient outcomes and reducing health disparities. The money comes from the National Cancer Institute’s Community Oncology Research Program (NCORP), part of the National Institutes of Health. Prisma Health is one of only 40 programs in the country to receive a NCORP grant.
The GHS Cancer Institute has received FACT accreditation for allogeneic stem cell transplantation. The Cancer Institute is one of only two programs in the state and the only program in the Upstate to earn FACT accreditation for both allogeneic and autologous stem cell transplants.
“Mom was active at 83—right up until she was diagnosed with cancer. During the next five years of treatments and hospital stays, one thing stands out: the amazing kindness and compassion of the doctors, nurses and staff of the GHS Cancer Institute.
The care she received inspired us to give back. Then we learned about the blood and marrow transplant (BMT) unit—and how having the unit right here means patients don’t leave families, homes and jobs for weeks at a time. I had no idea…”
Discover here what amazes Gary.